Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Wall Street Analysts Are Bullish on Top Consumer Goods Picks

Tipranks - Sun Mar 15, 11:46AM CDT

There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on SNDL (SNDLResearch Report) and Clene (CLNNResearch Report) with bullish sentiments.

Claim 70% Off TipRanks Premium

SNDL (SNDL)

In a report released yesterday, Aaron Grey from Alliance Global Partners maintained a Buy rating on SNDL, with a price target of $5.00. The company’s shares closed last Friday at $1.51, close to its 52-week low of $1.43.

According to TipRanks.com, Grey is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -7.2% and a 33.1% success rate. Grey covers the Healthcare sector, focusing on stocks such as Green Thumb Industries, Organigram Global, and Curaleaf Holdings. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for SNDL with a $4.75 average price target, implying a 198.7% upside from current levels. In a report released yesterday, ATB Cormark Capital Markets also maintained a Buy rating on the stock with a $4.50 price target.

See the top stocks recommended by analysts >>

Clene (CLNN)

Canaccord Genuity analyst Sumant Kulkarni maintained a Buy rating on Clene yesterday and set a price target of $48.00. The company’s shares closed last Friday at $5.72.

According to TipRanks.com, Kulkarni is a 4-star analyst with an average return of 5.8% and a 43.4% success rate. Kulkarni covers the Healthcare sector, focusing on stocks such as ACADIA Pharmaceuticals, Definium Therapeutics, and Voyager Therapeutics. ;'>

Currently, the analyst consensus on Clene is a Strong Buy with an average price target of $32.25, a 437.5% upside from current levels. In a report issued on March 5, Maxim Group also maintained a Buy rating on the stock with a $20.00 price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.